About the Authors

Justin M. Craig

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

Natalie Vena

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

Shakti Ramkissoon

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America

Ahmed Idbaih

Affiliation Hopital Pitie Salpetriere, Service de Neurologie Mazarin, Paris, France

Shaun D. Fouse

Affiliation Department of Neurosurgery, Brain Tumor Research Center, University of California San Francisco, San Francisco, California, United States of America

Memet Ozek

Affiliation Division of Pediatric Neurosurgery, Acibadem University Medical Center, Istanbul, Turkey

Aydin Sav

Affiliation Department of Pathology, Acibadem University Medical Center, Istanbul, Turkey

D. Ashley Hill

Affiliation Department of Pathology, Children’s National Medical Center, Washington, District of Columbia, United States of America

Linda R. Margraf

Affiliation Department of Pathology, The University of Texas Southwestern Medical Center, Children’s Medical Center, Dallas, Texas, United States of America

Charles G. Eberhart

Affiliation Departments of Pathology, Oncology and Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

Mark W. Kieran

Affiliations Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Andrew D. Norden

Affiliations Department of Neurology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Patrick Y. Wen

Affiliations Department of Neurology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Massimo Loda

Affiliations Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Sandro Santagata

Affiliations Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Keith L. Ligon

keith_ligon@dfci.harvard.edu (KL); aligon@rics.bwh.harvard.edu (AL)

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Azra H. Ligon

keith_ligon@dfci.harvard.edu (KL); aligon@rics.bwh.harvard.edu (AL)

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: JMC KLL AHL. Performed the experiments: JMC NV AI SR SS. Analyzed the data: JMC KLL AHL. Contributed reagents/materials/analysis tools: SDF MO AS DAH LRM CGE MWK PYW ADN ML SS KLL AHL. Wrote the paper: JMC KLL AHL.